SCHEMBL6617293

SCHEMBL6617293

O=CCN1CCc2ccc(N3CCNCC3)cc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 5/20 0.51
DRD3 P35462 2/20 0.51
MAPT P10636 5/20 0.43
ALDH1A1 P00352 3/20 0.43
ITGB3 P05106 3/20 0.43
ITGA2B P08514 3/20 0.43
MAPK1 P28482 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
ADRB1 P08588 6/20 0.41
POLB P06746 1/20 0.40
HTR3E A5X5Y0 3/20 0.40
HTR3B O95264 3/20 0.40
HTR3A P46098 3/20 0.40
HTR3D Q70Z44 3/20 0.40
HTR3C Q8WXA8 3/20 0.40
SIGMAR1 Q99720 3/20 0.40
TP53 P04637 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
HTR1A P08908 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5349708 0.82 HTR6 (0.51) HTR6DRD3MAPTALDH1A1ITGB3
SCHEMBL15638490 0.74 HTR2A (0.56) ALDH1A1CYP1A2CYP3A4CYP2D6HTR2A
SCHEMBL21635505 0.74 CHRM2 (0.49) DRD3MAPTALDH1A1CYP1A2CYP3A4
SCHEMBL12813197 0.74 ATAD2 (0.40) MAPTALDH1A1MAPK1POLBCYP1A2
SCHEMBL4985572 0.71 NOTUM (0.57) HTR6DRD3MAPTALDH1A1SMN1; SMN2
SCHEMBL7202158 0.70 HTR6 (0.61) HTR6DRD3ADRB1HTR3EHTR3B
SCHEMBL21635497 0.70 HDAC1 (0.46) DRD3SMN1; SMN2HTR2CHTR2B
SCHEMBL466270 0.70 ALDH1A1 (0.63) MAPTALDH1A1POLBCHRM2CHRM4
SCHEMBL931075 0.69 SIGMAR1 (0.48) SIGMAR1CYP1A2HTR1ACYP2D6HTR2A
SCHEMBL1758061 0.68 ADRB1 (0.55) HTR6ALDH1A1ADRB1HTR3EHTR3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1451158-A1 THERAPEUTIC QUINOLINE COMPOUNDS WITH 5-HT-ANTAGONISTIC PROPERTIES AstraZeneca AB (SE) 2004-09-01 EP disclosed
WO-2003037872-A1 THERAPEUTIC QUINOLINE COMPOUNDS WITH 5-HT-ANTAGONISTIC PROPERTIES ASTRAZENECA AB (SE) 2003-05-08 WO disclosed